This E-News is issued every other month to inform the international drug abuse research community about:
- What's New
- Funding Opportunities
- Research Training and Exchange Programs
- Press Releases From NIDA and the National Institutes of Health (NIH)
- Other Items of Interest
- Reading Corner
NIDA and Taipei Medical University Sign Binational Agreement
NIDA and Taipei Medical University, Taiwan, have agreed to cooperate on research into neuroprotection and drug abuse. NIDA Director Dr. Nora D. Volkow and Taipei Medical University President Dr. Wen-Ta Chiu signed a binational agreement to foster research training and research collaborations of mutual interest; further scientific and academic interactions between the two institutions; exchange researchers, trainees, and materials; and promote lectures, conferences, workshops, and seminars on neuroscience and drug abuse.
First IAS/NIDA Research Fellows in Drug Abuse and HIV/AIDS Selected
NIDA and the International AIDS Society (IAS) have announced the first two IAS/NIDA Research Fellows in Drug Abuse and HIV/AIDS. Michah Ongeri Oyaro, Ph.D., a research scientist at the University of Nairobi, Kenya, was selected for the 18-month postdoctoral fellowship. Maria Gudelia Rangel, Ph.D., a research associate and professor at El Colegio de la Frontera Norte in Tijuana, Mexico, was selected for the 8-month professional development fellowship for an established HIV researcher not currently working in the drug abuse field. The two $75,000 awards were announced at the IAS Conference on HIV Pathogenesis, Treatment and Prevention, which took place in Cape Town, South Africa, July 19–22, 2009. Dr. Oyaro will work with John Wylie, Ph.D., University of Manitoba, Canada, to design and conduct a study of social networks, serostatus, and molecular epidemiology of HIV, hepatitis B (HBV), and hepatitis C (HCV) infections among drug abusers in Kenya. The research findings will inform future vaccine development and immediate intervention measures to address viral transmission through education, immunization, provision of condoms, and treatment strategies. Dr. Rangel has spent more than 15 years working in the field of HIV and migration, and now wishes to re-orient her career to study HIV in the context of substance abuse. She will work with Dr. Steffanie Strathdee, University of California San Diego, to investigate HIV prevalence among clients in substance abuse rehabilitation centers in Baja California, Mexico. The project findings will add significantly to the limited data on HIV among Mexican drug users, with potential implications for Mexican state and national drug policies.
NIDA International Forum Focuses on Commonalities Among the Diseases of Addiction
Drugs. Sex. Gambling. Obesity.
Plenary session speakers at the 14th NIDA International Forum documented the commonalities among these “Disorders of Desire,” citing clear overlaps in implicated brain regions and similar patterns of compulsive self-administration, tolerance, craving, comorbidity, disruption of inhibitory control, and impaired decision-making. Dr. Timothy Condon, NIDA Deputy Director, reviewed the Institute’s priority research areas and reported on the Institute’s signature projects to eradicate tobacco addiction and elucidate the genetics of brain development, and initiatives to prevent and treat substance abuse among military personnel and veterans.
NIDA International Program Director Dr. Steven W. Gust chaired the meeting, which was held June 19–23, 2009, in Reno, Nevada, as a satellite to the Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD). More than 250 participants from 48 countries participated in the plenary session, workshops, and networking activities. A joint CPDD/NIDA International Forum poster session featured presentations by 150 U.S. and international researchers as well as representatives from 10 NIDA components. The NIDA International Program also supported a second CPDD satellite, Treating Addiction During Pregnancy: Exploring Multinational Perspectives To Build a Treatment Approach Consensus.
Save the Date: 2010 NIDA International Forum
June 11–16, 2010
The Fairmont Scottsdale
Abstract Submission and Travel Award Application Deadline: February 8, 2010
2009 Awards of Excellence
Excellence in Mentoring
James C. (Jim) Anthony, M.Sc., Ph.D.
Department of Epidemiology
Michigan State University College of Human Medicine
East Lansing, Michigan, United States
Excellence in International Leadership
Ian Stolerman, B.Pharm., Ph.D.
Section of Behavioural Pharmacology
Institute of Psychiatry
King’s College London, United Kingdom
Excellence in Collaborative Research
Steffanie A. Strathdee, Ph.D.
Department of Medicine
University of California San Diego School of Medicine
San Diego, California, United States
María Remedios Lozada Romero, M.D.
Baja California State
Carlos Magis-Rodríguez, M.D., M.P.H.
Department of Research
Mexico City, Mexico
NIDA International Research Interests and Opportunities (1.7MB)
During the June 2009 NIDA International Forum poster session, representatives from 10 NIDA components and the Fogarty International Center of the National Institutes of Health presented posters summarizing the units' goals, research interests, international focus, and international funding priorities.
NIDA International Program 2008 Annual Report (2.1MB)
The 2008 Annual Report demonstrates how the NIDA International Program links the Institute to research organizations and scientists throughout the world, providing the opportunity for collaborators to develop knowledge jointly that neither partner could have developed independently.
NIDA International Program Introduces Forum Abstract Database
Research abstracts accepted for poster presentation at NIDA International Forums from 2003 through 2009 are now available in a searchable online database. Users may look for abstracts by author, title/subject, year, research category (basic science, epidemiology, prevention, or treatment), country, or geographic region.
World Drug Report Focuses on Drug-Related Crime
The United Nations Office on Drugs and Crime (UNODC) 2009 World Drug Report reports that global markets for cocaine, opiates, and cannabis are steady or in decline, while production and use of amphetamine-type stimulants (ATS) might be increasing in the developing world. Cannabis remains the most widely used drug around the world, and data show that it is more harmful than commonly believed. The average THC content of hydroponic marijuana in North America almost doubled in the past decade, and the number of people seeking treatment rose significantly. Addressing the impact of drug-related crime, the report recommends reducing demand by providing universal access to drug treatment and improving housing, jobs, education, public services, and recreation opportunities. UNODC estimates that there were between 18 and 38 million problem drug users age 15–64 in 2007. Cannabis remained the primary drug of abuse in Africa (63%) and Oceania (47%), while opiates were the primary cause of drug treatment requests in Asia (65%) and Europe (60%). Cocaine was more prominent in North America (34%) and South America (52%) than in other regions; and ATS were more prominent in Asia (18%), North America (18%), and Oceania (20%). Injecting drug use has been documented in 148 countries; China, the United States, the Russian Federation, and Brazil are estimated to account for 45 percent of the total estimated worldwide population of injecting drug users (IDUs). Regions with the largest numbers and highest concentration of HIV-positive IDUs include Eastern Europe, East and South East Asia, and Latin America. The newly appointed Director of the U.S. Office of National Drug Control Policy (ONDCP), Gil Kerlikowske, joined UNODC Executive Director Antonio Maria Costa to launch the new report, promising U.S. support for international demand-reduction initiatives and increased access to effective treatment programs, especially in developing countries.
UNAIDS, World Bank Warn Economic Crisis Threatens HIV Treatment and Prevention
A June 2009 report from the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Bank finds that HIV treatment and prevention programs are threatened by the global economic crisis due to adverse impacts on the affordability of antiretroviral treatment, declining food security, budget cuts, and decreases in external aid programs. The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact (1.1MB) reports on a March 2009 survey of 71 countries. Respondents say that efforts to scale up treatment access will stall and that prevention efforts for populations at higher risk are especially vulnerable, because they are politically easier to cut. Medical and economic analyses of the HIV epidemic conclude that these reductions in treatment and prevention programs are likely to result in increased mortality and morbidity, greater transmission risks, higher future financial costs, increased burdens on health systems, and reversal of economic and social development gains. Michel Sidibé, the new UNAIDS Executive Director, warns that for every two people who start antiretroviral treatment, five people are newly infected with HIV.
International Research Collaboration on Drug Addiction
International Research Collaborations on HIV/AIDS and Drug Use: RFA-DA-10-008
Letters of Intent Due: October 18, 2009
Applications Due: November 18, 2009
Upcoming Program Announcement Receipt Dates From Fogarty International Center
- AIDS International Training and Research Program: August 14, 2009
- Brain Disorders in the Developing World/AIDS Applications (R01 and R21): August 21, 2009
- FIRCA (Basic Biomedical and Behavioral and Social Sciences): September 29, 2009
- Global Research Initiative Program for New Foreign Investigators (Basic Biomedical and Behavioral and Social Sciences)
- AIDS Applications: September 21, 2009
- Non-AIDS Applications: December 18, 2009
- ICOHRTA AIDS/TB: August 18, 2009
- Program Application Deadlines and Review Cycle Dates
- Directory of Grants and Fellowships in the Global Health Sciences
Upcoming Application Deadlines
- Resources for International Librarians, Health Professionals, and Researchers in Developing Countries
Publishing Addiction Research Internationally: www.PARINT.org
International Drug, Alcohol and Tobacco Research Community
NOTE: The following information is being provided for informational purposes only. Reference to any Web site listed below does not constitute endorsement or recommendation by NIDA/NIH/HHS.
The International Certification in Addiction Medicine for physicians.
Access to Free or Low-Cost Online Publications for Researchers
- International Network for the Availability of Scientific Publications (INASP)
- HINARI – Health InterNetwork Access to Research Initiative
Look here for research articles or other publications that may be of interest to the international drug abuse research community.